Roche Investor Update: Invitation to Roche's Full Year Results 2017 Presentation Montag, 08. Januar 2018 - 14:06
Invitation to Roche's Full Year Results 2017 Presentation | |
|---|
|
|---|
Roche will publish its Full Year Results for 2017 prior to the opening of the Swiss Stock Exchange on Thursday, 1 February 2018.
7:00 CET / 6:00 GMT / 1:00 AM EST / 10:00 PM PST (evening before)
Release will be e-mailed and posted on the Roche IR website click > click here .
Presentation slides will be posted on the Roche IR website click > click here .
We would like to invite all interested parties to participate or dial in to the event outlined below.
Thursday, 1 February 2018, London
The Full Year Presentation followed by Q&A and additional break-out sessions will be held at the
London Stock Exchange, The Theatre, 10 Paternoster Square, London EC4M 7LS >map
Presenters: - Severin Schwan, CEO Roche Group
- Daniel O'Day, CEO Roche Pharmaceuticals
- Roland Diggelmann, CEO Roche Diagnostics
- Alan Hippe, Chief Financial and IT Officer
Meeting information:
1 February 2018
Time (GMT):
14:30 Registration
15:00 Meeting starts
17:30 Meeting ends, followed by a buffet reception
Break-out sessions covering the topics Strategy, Finance & Accounting, Pharmaceuticals and Diagnostics will be held following the main Q&A.
Following the event we would also like to invite you to drinks and canapés to give you the opportunity to speak to management more informally.
Please make sure you have identification and allow enough time to go through the London Stock Exchange security check.
To register for the event, please follow the > link
This presentation can also be accessed through a live video webcast:
> click here .
In order to receive your personal dial-in details and expedite your access to the conference call, please pre-register under this link > click here .
If you have not pre-registered please find the dial-in numbers below, we recommend you to dial in to the conference 10-15 min prior to the scheduled start:
+41 (0) 58 310 50 00 (Europe and ROW) or
+44 (0) 207 107 0613 (UK) or
+1 (1) 631 570 5613 (USA)
Replay
A replay of the video webcast will be available on demand on the Roche website.>click here .
Best regards,
Karl Mahler
Head of Investor Relations |
|---|
|
|---|
Investor Relations North America
| |
|---|
|
|---|
